---
document_datetime: 2025-04-10 15:04:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ebglyss-epar-all-authorised-presentations_en.pdf
document_name: ebglyss-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7600818
conversion_datetime: 2025-12-19 06:08:28.68431
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|-------------------------------------------|
| EU/1/23/1765/001 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 1 pre-filled syringe                      |
| EU/1/23/1765/002 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 2 pre-filled syringes                     |
| EU/1/23/1765/003 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 3 pre-filled syringes                     |
| EU/1/23/1765/004 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 4 (2 x 2) pre-filled syringes (multipack) |
| EU/1/23/1765/005 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 5 (5 x 1) pre-filled syringes (multipack) |
| EU/1/23/1765/006 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 2 ml (125 mg/ml)          | 6 (3 x 2) pre-filled syringes (multipack) |
| EU/1/23/1765/007 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 1 pre-filled pen                          |
| EU/1/23/1765/008 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 2 pre-filled pens                         |
| EU/1/23/1765/009 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 3 pre-filled pens                         |
| EU/1/23/1765/010 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 4 (2 x 2) pre-filled pens (multipack)     |
| EU/1/23/1765/011 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 5 (5 x 1) pre-filled pens (multipack)     |
| EU/1/23/1765/012 | Ebglyss           | 250 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 2 ml (125 mg/ml)          | 6 (3 x 2) pre-filled pens (multipack)     |